Aditya Birla Sun Life Pharma & Healthcare Fund - IDCW - Direct Plan

  • Previous Nav

  • Net Change on 17-05-2024

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Direct Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
NIFTY 50 - TRI N/A N/A N/A N/A N/A N/A
S&P BSE Health Care - TRI 1.28 -0.09 54.47 14.47 22.69 15.26

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option Jan 01, 2013 54.89 15.98 26.15 0.92 7,132.82
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Direct Plan - IDCW Option Jul 13, 2018 58.08 17.29 27.49 1.03 3,834.82
SBI Healthcare Opportunities Fund - Direct Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jan 01, 2013 53.19 17.65 26.89 0.95 2,667.21
DSP Healthcare Fund - Direct Plan - IDCW Nov 30, 2018 52.64 18.26 29.01 0.66 2,343.94
Mirae Asset Healthcare Fund Direct IDCW Jul 02, 2018 52.01 15.91 27.50 0.50 2,236.01

Fund Holdings as on 30-April-2024

  • Sun Pharmaceutical Industries Limited

  • Cipla Limited

  • Torrent Pharmaceuticals Limited

  • Apollo Hospitals Enterprise Limited

  • Clearing Corporation of India Limited

  • Fortis Healthcare Limited

  • Zydus Lifesciences Limited

  • Ajanta Pharmaceuticals Limited

  • Aurobindo Pharma Limited

  • Lupin Limited

  • Gland Pharma Limited

  • Alkem Laboratories Limited

  • ALEMBIC PHARMACEUTICALS LIMITED

  • J.B. Chemicals & Pharmaceuticals Limited

  • Abbott India Limited

  • Dr. Reddys Laboratories Limited

  • Sanofi India Limited

  • Strides Pharma Science Limited

  • Jupiter Life Line Hospitals Ltd

  • Vijaya Diagnostic Centre Limited

  • Star Health & Allied Insurance Limited

  • Mankind Pharma Ltd

  • Medi Assist Healthcare Services Ltd

  • Granules India Limited

  • Eris Lifesciences Limited

  • Biocon Limited

  • Medplus Health Services Limited

  • Vinati Organics Limited

  • Net Receivables / (Payables)

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Insurance

  • Business Support

  • Chemicals

View More

About Aditya Birla Sun Life Pharma & Healthcare Fund

Scheme Analysis

Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to Aditya Birla Sun Life Mutual Fund. It was launched on 10-Jul-2019 and currently has an AUM of ₹694.50 crore. Aditya Birla Sun Life Pharma & Healthcare Fund is benchmarked against NIFTY 50 - TRI as primary index and S&P BSE Health Care - TRI as secondary index.

The NAV of Aditya Birla Sun Life Pharma & Healthcare Fund ended up ₹0.04(0.19%)yesterday to ₹21.39.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Limited, and

The Aditya Birla Sun Life Pharma & Healthcare Fund is managed by Dhaval Shah .

Fund House Contact

One World Center , Tower 1, 17th Floor, Jupiter Mill Compound, Senapati Bapat Marg, Elphinstone Road, Mumbai - 400 013

022-43568000
022-43568110/ 8111